IMGN - ImmunoGen Inc. (IMGN) CEO Mark Enyedy on Q1 2022 Results - Earnings Call Transcript

ImmunoGen, Inc. (IMGN) Q1 2022 Results Conference Call May 06, 2022 08:00 AM ET Company Participants Courtney O'Konek - Senior Director, Corporate Communications Mark Enyedy - President, CEO Anna Berkenblit - CMO Kristen Harrington-Smith - Chief Commercial Officer Susan Altschuller - CFO Conference Call Participants Boris Peaker - Cowen Kelly Shi - Jefferies Etzer Darout - BMO Capital Markets Jessica Fye - JPMorgan John Newman - Canaccord Joe Catanzaro - Piper Sandler Michael Schmidt - Guggenheim Andy Hsieh - William Blair Jonathan Chang - SVB Securities Presentation Operator Good morning and welcome to ImmunoGen's First Quarter 2022 Financial and Operating Results Conference Call. Today's conference is being recorded. At this time, I'd like to turn the call over to Courtney O'Konek, Senior Director of Corporate Communications. Please go ahead. Courtney O'Konek Good morning, and thank you for joining today's call. Earlier today, we issued a press release that includes a

For further details see:

ImmunoGen, Inc. (IMGN) CEO Mark Enyedy on Q1 2022 Results - Earnings Call Transcript